• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Rabbit anti-Human SRBD1 Polyclonal Antibody

The antibody against SRBD1 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 330-600 of human SRBD1 (NP_060549.4) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

ADA-03530A

The antibody against SRBD1 was raised in Rabbit using the recombinant fusion protein containing a sequence corresponding to amino acids 330-600 of human SRBD1 (NP_060549.4) as the immunogen. The polyclonal antibody exists as a isotype IgG, by affinity purification. This antibody has been validated on WB, ELISA.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ADA-03530A ClonalityPolyclonal
Host SpeciesRabbitTarget NameSRBD1
Target SynonymsSRBD1FormLiquid
Species ReactivityHuman, Mouse, RatIsotypeIgG
Storage Buffer50% Glycerol, PBS with 0.01% thimerosal, pH7.3.Purification MethodAffinity purification
Positive SamplesRat brain, 293T, A-549, Mouse testis, Rat testisApplicationELISA, WB

Immunogen Information


Immunogen DescriptionRecombinant fusion protein containing a sequence corresponding to amino acids 330-600 of human SRBD1 (NP_060549.4).Target SpeciesHuman
Uniprot IDQ8N5C6Immunogen Sequence
Background Information
  • Uniprot Id

    Q8N5C6

  • Target Species

    Human

  • Target Name

    SRBD1

  • Target Full Name

    S1 RNA-binding domain-containing protein 1

  • Target Synonyms

    FLJ10379; S1 RNA binding domain 1; S1 RNA binding domain containing protein 1; S1 RNA-binding domain-containing protein 1; SRBD 1; Srbd1; SRBD1_HUMAN

Inquire Rabbit anti-Human SRBD1 Polyclonal Antibody Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification